Gyula Zsidei
Research Subjects
Research Interests
Gyula Zsidei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bereniké Novák
National Biosafety Laboratory, National Center for Public Health and Pharmacy, 1097 Budapest, Hungary
1 shared publication - Bernadett Pályi
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, 1097 Budapest, Hungary
1 shared publication - Béla Dénes
National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, Budapest, Hungary
1 shared publication - Dániel Déri
National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary
1 shared publication - Judit Henczkó
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, 1097 Budapest, Hungary
1 shared publication - Nóra Deézsi-Magyar
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, H-1097 Budapest, Hungary
1 shared publication
Latest Publications
- Open Access
First Broad-Range Serological Survey of Crimean–Congo Hemorrhagic Fever among Hungarian Livestock
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.
Open AccessFirst Broad-Range Serological Survey of Crimean–Congo Hemorrhagic Fever among Hungarian Livestock
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.